Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures

This non-interventional, observation study is to collect real-world data on the use of an autologous, hair follicle derived secretome topical cosmetic product following various medical aesthetic procedures.

Inclusion criteria

• Male and Female
• Ages: 18-60
• Any Fitzpatrick skin type
• Planning a medical aesthetic procedure
• For subjects receiving hair procedures (closed to enrollment):

• Androgenic alopecia
• Traction alopecia
• Scarring alopecia
• Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
• No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
• Undergoing one of the following medical aesthetic procedures:

• Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
• Tixel of the face
• Keralase of the scalp (scalp treatment closed to enrollment)
• Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
• Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product

Exclusion criteria

• Pregnant or Breastfeeding
• Participation in an interventional clinical trial in the last 30 days
• Use of other topical cosmetic products that may confound results
• Use of retinoids within 7 days prior to facial procedure
• For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
• Any health condition that in the investigator's opinion should preclude participation in study